Cannabis Law Report

MAY 10, 2022

Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Since the beginning of the program, medicinal cannabis has been prescribed for over 140 conditions.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Cannigma

AUGUST 26, 2021

percent), according to the United Nations World Drug Report for 2020.In In addition, a survey published in July 2020 found that 41% of Australians support cannabis legalization, and 37% are opposed. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? A 2020 study found that all symptoms of PTSD were reduced by more than 50% immediately after cannabis consumption.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

SEPTEMBER 1, 2021

Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline. The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. Field Trip Health Ltd.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. While its psilocybin and MDMA trials progress, the company is expanding its psychedelics research laboratory.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JULY 9, 2021

On November 3, 2020, Oregon became the first state to decriminalize psilocybin for recreational purposes. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. Id ; 21 CFR 312.1-10;

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

MAY 29, 2022

In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. Clinical Trials and Human Subject Protections. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects. 20, 2020), [link]. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

DECEMBER 17, 2021

In 2020, the total prevalent cases of 22q11.2 deletion syndrome cases in the 7MM, accounting for approximately 42% of the total 7MM cases in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were 35,203 in 2020.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? First, here’s everything you need to know before you make a decision.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is the largest national chain of ketamine infusion clinics in the United States and will add to Delic’s existing portfolio of two clinics operated by Ketamine Infusion Centers in California and Arizona , cementing its position as the leading and largest health provider in the country.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. Clinical stage CBD company Botanix Pharmaceuticals (ASX: BDA ) works on using cannabidiol (CBD) in its treatment of skin conditions including acne, psoriasis, dermatitis and rosacea.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Treatment for many serious medical conditions can be very expensive, and drugs that have no government approval do not get insurance coverage. National legalisation of medical cannabis could occur as early as 2020 in Spain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Puff Puff Post

JANUARY 1, 2020

As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Treatment for many serious medical conditions can be very expensive, and drugs that have no government approval do not get insurance coverage. National legalisation of medical cannabis could occur as early as 2020 in Spain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Project CBD

FEBRUARY 28, 2023

This was somewhat less than the nearly 37% decline seen in 2020. decline from 2020. Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Accessed July 25, 2021.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

DECEMBER 7, 2021

The search included studies through 11-May-2020. Since 2017, several clinical trials and observational studies have examined the efficacy of MCs in the pediatric population for a few indications, most of them focused on CBD efficacy in Dravet syndrome 28 , 29 , 30. Results.

Safety 52

Safety Cannabinoids Events Data 52

CannaMD

APRIL 23, 2020

Michael Farley , the President and Director of GBS Global Biopharma, the Canadian wing of GB Sciences, spoke to the study’s implications for the future: We look forward to bringing these promising formulations into human clinical trials as early as 2020. FDA in order to enter human clinical trial as early as this year!

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Marijuana Heart Study Summary. population, has an arrhythmia.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

SMPL

MAY 26, 2020

But the CBD landscape of 2020 looks nothing like what the activists and scientists intended. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

NOVEMBER 7, 2019

As of August 2019, authorities in Australia have granted approximately 14,500 approvals, under the Special Access Scheme, for the legal use of medicinal cannabis. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. Governor Ducey (R-AZ) opposes legalization.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 12, 2021

SAN DIEGO–(BUSINESS WIRE)– #CBD — Radicle Science , a transformative healthtech B-corp validating consumer health products for the first time, secured its initial seed funding in Q4 2020 and surpassed numerous major milestones with accelerating momentum in the first three quarters of 2021. Notably, Peter H.

Clinical Trials 52

Clinical Trials Research and Development Sleep Cannabinoids 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Published in late 2020, Brian has since appeared on dozens of media outlets, including Joe Rogan’s podcast, CNN, and Vice.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. People are not enthused about prohibiting medical care.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access. After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies.

Legislation 59

Legislation Patients Access Banking 59